evotaz
bristol-myers squibb pharma eeig - cobicistat, atazanavir - hiv infektioner - antivirale midler til systemisk anvendelse - evotaz is indicated in combination with other antiretroviral medicinal products for the treatment of hiv-1 infected adults and adolescents (aged 12 years and older weighing at least 35 kg) without known mutations associated with resistance to atazanavir (see sections 4. 4 og 5.
atazanavir "teva" 200 mg kapsler, hårde
teva b.v. - atazanavirsulfat - kapsler, hårde - 200 mg
atazanavir "teva" 150 mg kapsler, hårde
teva b.v. - atazanavirsulfat - kapsler, hårde - 150 mg
atazanavir "teva" 300 mg kapsler, hårde
teva b.v. - atazanavirsulfat - kapsler, hårde - 300 mg
atazanavir "accord" 200 mg kapsler, hårde
accord healthcare b.v. - atazanavirsulfat - kapsler, hårde - 200 mg
atazanavir "accord" 300 mg kapsler, hårde
accord healthcare b.v. - atazanavirsulfat - kapsler, hårde - 300 mg
atazanavir "stada" 150 mg kapsler, hårde
stada arzneimittel ag - atazanavirsulfat - kapsler, hårde - 150 mg
atazanavir "stada" 200 mg kapsler, hårde
stada arzneimittel ag - atazanavirsulfat - kapsler, hårde - 200 mg
atazanavir "stada" 300 mg kapsler, hårde
stada arzneimittel ag - atazanavirsulfat - kapsler, hårde - 300 mg
irinokabi 20 mg/ml koncentrat til infusionsvæske, opløsning
fresenius kabi ab - irinotecanhydrochloridtrihydrat - koncentrat til infusionsvæske, opløsning - 20 mg/ml